FDA Inspection 748712 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3004664162

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on September 29, 2011 in Hikari. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 29, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hikari (Japan)